APCCC 2021: What Is the Evidence for “Triplet Therapy” (ADT + Radiation of the Primary + Additional Systemic Therapy)?

(UroToday.com) The Advanced Prostate Cancer Consensus Conference 2021 meeting session discussing management of newly diagnosed metastatic hormone-sensitive prostate cancer (mHSPC) included a presentation by Dr. Karim Fizazi regarding the evidence for “triplet therapy”, specifically ADT + radiation + primary additional systemic therapy.